Teva Employees Sell More Than Third Of Stock Options
This article was originally published in PharmAsia News
Executive Summary
Employees of Israel's Teva Pharmaceuticals sold the majority of their stock in the company last year, for a collective profit of $222 million, a 38 percent increase over 2009